Part 1- Lithium: Why it’s still Firstline

From my experience and extensive reading, lithium truly stands out among mood stabilizers for bipolar disorder because it works effectively across all phases of the illness—both acute mania and maintenance. One of the most remarkable benefits of lithium is its consistent association with reducing the risk of suicide and self-harm, an outcome that sets it apart from many other treatments. This isn’t just about managing symptoms but about improving long-term survival, which is crucial. While many patients and clinicians hesitate to use lithium due to concerns about safety and the need for regular monitoring, in my observation, when lithium is managed correctly with careful monitoring of renal function, thyroid levels, and serum lithium, most risks can be minimized. Long-term side effects are often dose-dependent and more likely when comorbidities like hypertension and diabetes are present. Additionally, ongoing studies hint at lithium’s potential neurobiological benefits beyond mood stabilization, including effects on neuronal signaling and cellular resilience, which could contribute to its protective effects. Given these findings, lithium remains a reliable cornerstone in treating bipolar disorder. In practice, ensuring patient adherence to monitoring schedules and educating them about lithium’s benefits and risks are key steps I’ve found helpful. Many patients appreciate understanding that lithium is not an outdated treatment but one of the most evidence-supported medications still available, with decades of real-world use backing its safety and efficacy when used properly. If you or someone you know is living with bipolar disorder, discussing lithium as an option with a knowledgeable healthcare provider, who can provide individualized monitoring and support, may be worthwhile. It’s a proven contender that continues to save lives and improve quality of life.